Date | Time | Source | Headline | Symbol | Company |
09/10/2024 | 3:00PM | iHub Newswire | FeaturedElement79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates | | |
06/30/2009 | 4:25PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
06/30/2009 | 4:25PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
06/22/2009 | 6:22PM | PR Newswire (US) | The Microcap Underground on Stocks to Watch: Oncothyreon Inc, Forest Labs, and Johnson & Johnson | NYSE:FRX | Forest Road Acquisition Corp |
06/22/2009 | 9:20AM | PR Newswire (US) | Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham | NYSE:FRX | |
06/19/2009 | 2:40PM | Dow Jones News | Forest Labs Reports Upbeat Pneumonia Drug Test Results | NYSE:FRX | Forest Laboratories Inc. |
06/19/2009 | 1:25PM | PR Newswire (US) | Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Commu | NYSE:FRX | Forest Road Acquisition Corp |
06/19/2009 | 12:38PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NYSE:FRX | Forest Road Acquisition Corp |
06/17/2009 | 12:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/12/2009 | 9:31AM | PR Newswire (US) | Critical Alerts for SLB, S, BCS, WLT, and FRX Released by Seven Summits Research | NYSE:FRX | Forest Road Acquisition Corp |
06/11/2009 | 11:15AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/11/2009 | 7:23AM | Marketwired | TheFortuneFinancial.com Free Market Research on EK, CL, EXR and FRX | NYSE:FRX | Forest Road Acquisition Corp |
06/10/2009 | 3:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/10/2009 | 3:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/10/2009 | 3:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/10/2009 | 10:54AM | Dow Jones News | PHARMA MARKET: Wyeth Stands By Pristiq After Slow Start | NYSE:FRX | Forest Laboratories Inc. |
05/31/2009 | 11:45AM | PR Newswire (US) | Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome | NYSE:FRX | Forest Road Acquisition Corp |
05/29/2009 | 3:59PM | Edgar (US Regulatory) | Annual Report (10-K) | NYSE:FRX | Forest Road Acquisition Corp |
05/28/2009 | 11:39AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/22/2009 | 4:34PM | Dow Jones News | Drug Makers To Pay $89 Million To Settle Alabama Medicaid Price Suits | NYSE:FRX | Forest Laboratories Inc. |
05/20/2009 | 11:31AM | Marketwired | WallStSense.com Free Research Report for Shareholders of FRX, GD, GES and GT | NYSE:FRX | Forest Road Acquisition Corp |
05/18/2009 | 5:23PM | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NYSE:FRX | Forest Road Acquisition Corp |
05/12/2009 | 8:00AM | PR Newswire (US) | Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide | NYSE:FRX | Forest Road Acquisition Corp |
05/05/2009 | 11:03AM | Dow Jones News | 2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZeneca | NYSE:FRX | Forest Laboratories Inc. |
04/30/2009 | 4:01AM | Dow Jones News | Almirall, Forest See New Drug Application For COPD By 2012 | NYSE:FRX | Forest Laboratories Inc. |
04/23/2009 | 10:40AM | Marketwired | AnalystChoice.com Free Investment Opinion on STT, LXK, CBS and FRX | NYSE:FRX | Forest Road Acquisition Corp |
04/21/2009 | 1:15PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/21/2009 | 9:09AM | Dow Jones News | Forest Labs 4Q Net Drops 46% Amid Marketing Probe Set-Aside | NYSE:FRX | Forest Laboratories Inc. |
04/21/2009 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2009 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) | NYSE:FRX | Forest Road Acquisition Corp |